Why the study?
Does anticoagulant therapy reduce thromboembolic complications in patients with acute myocardial infarction?
Does anticoagulant therapy reduce thromboembolic complications in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Anticoagulant therapy reduces the incidence of serious and fatal embolic complications in patients with acute myocardial infarction without significantly increasing death from hemorrhage.
Autopsy records of 151 patients dying of acute myocardial infarction, in a large private hospital, were reviewed. Half of the patients received anticoagulant therapy. Hemorrhage was not a significant cause of death in Dicumarol-treated patients. Embolic complications, often undiagnosed clinically, were of common occurrence. Adequate anticoagulant therapy effectively reduced, not only the total number of emboli, but also the number of serious or fatal emboli. In this role, anticoagulants serve a useful purpose in the treatment of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Glueck et al. (1956) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: